In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization.

[1]  Karin Baier,et al.  Medical Physiology Principles For Clinical Medicine , 2016 .

[2]  H. Ghandehari,et al.  Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[3]  J. Dufour,et al.  Intermediate hepatocellular carcinoma: current treatments and future perspectives. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  S. Friedman,et al.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. , 2013, Gastroenterology.

[5]  A. Lewis,et al.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Hamidreza Ghandehari,et al.  Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery. , 2012, International journal of pharmaceutics.

[7]  J. Bruix,et al.  Hepatocellular carcinoma , 2012, The Lancet.

[8]  R. A. Rhoades.  Comprar Medical Physiology, PRINCIPLES FOR CLINICAL MEDICINE | R.A. Rhoades | 9781451110395 | Lippincott Williams & Wilkins , 2012 .

[9]  D. Sze,et al.  Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. , 2012, Journal of vascular and interventional radiology : JVIR.

[10]  K. McGlynn,et al.  International Liver Cancer Incidence Trends—Letter , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[11]  R. Gillies,et al.  Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. , 2011, Journal of medicinal chemistry.

[12]  T. Vogl,et al.  Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations , 2011, CardioVascular and Interventional Radiology.

[13]  K. Leung,et al.  Chemoembolization agents for cancer treatment. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  Ahmedin Jemal,et al.  International Trends in Liver Cancer Incidence Rates , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[15]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[16]  Robert W Barber,et al.  Biomimetic Design of Artificial Micro-vasculatures for Tissue Engineering , 2010, Alternatives to laboratory animals : ATLA.

[17]  M. Caraglia,et al.  Latest developments in targeted therapy for hepatocellular carcinoma , 2010, Expert review of anticancer therapy.

[18]  J. Bruix,et al.  Two decades of advances in hepatocellular carcinoma research. , 2010, Seminars in liver disease.

[19]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Cresce,et al.  Silk–elastinlike protein polymer hydrogels: Influence of monomer sequence on physicochemical properties , 2009 .

[21]  Recombinant Biomaterials for Pharmaceutical and Biomedical Applications , 2008, Pharmaceutical Research.

[22]  A. Laurent.  Microspheres and nonspherical particles for embolization. , 2007, Techniques in vascular and interventional radiology.

[23]  T. Clark.  Complications of hepatic chemoembolization. , 2006, Seminars in interventional radiology.

[24]  Robert W Barber,et al.  Biomimetic design of microfluidic manifolds based on a generalised Murray's law. , 2006, Lab on a chip.

[25]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .

[26]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[27]  K. Brown.  Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres. , 2004, Journal of vascular and interventional radiology : JVIR.

[28]  J. Bruix,et al.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.

[29]  H. Ghandehari,et al.  Engineered protein polymers for drug delivery and biomedical applications , 2002 .

[30]  J. Cappello,et al.  In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[31]  L. Blumgart,et al.  Surgery of the liver and biliary tract , 1994 .

[32]  M. Marquet,et al.  Genetic Engineering of Structural Protein Polymers , 1990, Biotechnology progress.

[33]  P. Gaehtgens,et al.  Erythrocyte flow velocities in mesenteric microvessels of the cat. , 1970, Microvascular research.

[34]  C D Murray,et al.  The Physiological Principle of Minimum Work: I. The Vascular System and the Cost of Blood Volume. , 1926, Proceedings of the National Academy of Sciences of the United States of America.